Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children

- Growth Hormone-Deficiency
- Terminated

Study Title: A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children

Teva Identifier: TV1106-IMM-20001 | 2013-004468-69

ClinicalTrials.gov Identifier: NCT02092077

Study Status: Terminated

Trial Condition(s): Growth Hormone-Deficiency

Interventions: Drug: TV-1106 | Drug: somatropin

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child

Age Range: 3 Years to 11 Years

Trial Duration: April 30, 2014 - August 31, 2016

Phase: Phase 2

Study Type

Interventional